Recent Developments with Metalloprotease Inhibitor Class of Drug Candidates for Botulinum Neurotoxins

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|15|7|685-695

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.15, Iss.7, 2015-04, pp. : 685-695

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Searching for Therapeutics Against Botulinum Neurotoxins: A True Challenge for Drug Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 21, 2016-06 ,pp. : 2330-2349

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Drug Candidates of Dipeptidyl Peptidase IV (DPP IV) Inhibitor Class for the Treatment of Type 2 Diabetes

By  

Current Drug Targets, Vol. 10, Iss. 1, 2009-01 ,pp. : 71-87

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Botulinum Neurotoxin Inhibitor Development

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 18, 2014-09 ,pp. : 2044-2061

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in Antimalarial Drug Discovery

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 5, Iss. 1, 2006-01 ,pp. : 105-122

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in Taxane Drug Delivery

By  

Current Drug Delivery, Vol. 5, Iss. 1, 2008-01 ,pp. : 42-54

Bentham Science Publishers

Access to resources Recommend Favorite